Arthneeti
S

Sigachi Industries Ltd

Q4 FY26Pharmaceuticals & Biotechnology

Sigachi Industries Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹30
Market cap₹995 Cr
P/E30.6
Updated23 Aug 2026
Read4 min read

What the Q4 FY26 call signalled

4 of 4 strong

RevenueGood growth
MarginMargins up
CapexCapex planned
FundraiseFundraise planned

The short version

Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reaching

From Sigachi Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Good growth
  • Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix.
  • Expansion includes 12,000 metric tons capacity increase at Dahej H2 with CapEx of INR 106 crores, plus new CCS capacity (~INR 90 crores CapEx) expected to commercialize by Q1 FY28.
  • Full capacity including MCC and CCS is expected to boost revenues significantly beyond FY27; the company targets INR 1000 crores turnover by around FY29.
  • Volume growth expected from capacity expansion (from current 18,000 metric tons plus an additional 12,000 metric tons).
  • API segment revenue is projected to increase from 14% to about 18-20% of total revenue, adding to topline growth.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Sigachi Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Ongoing CapEx for expanding MCC capacity by 12,000 metric tons at Dahej H2 with a cost of around INR 106 crores.
  • CapEx for CCS project totaling around INR 90 crores, expected to commercialize by Q1 FY28.
  • Dahej has 20 acres of land and Kurnool has 25 acres available for future capacity expansions.
  • Plans to gradually increase capacities based on market demand, targeting 50,000-70,000 metric tons in the coming years.

2 more points management made on capital expenditure plans

Top-ranked in Pharmaceuticals & Biotechnology

Ranked on what management guided this quarter

5x potential
1KRM Ayurveda Ltd
Rev 1Mar 1
2Accretion Pha.
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sigachi Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company mentioned ongoing business talks and some clients already lined up supporting revenue growth.
  • Expected revenue from the new 12,000 metric tons capacity expansion is around INR 200-220 crores.
  • From the Contract Custom Synthesis (CCS) segment, approximately INR 100 crores of revenue is anticipated.
  • Demand for CCS is good, with inquiries and customers requesting dispatches alongside MCC, indicating a healthy order pipeline.
  • Current focus is on gradually increasing MCC utilization from 75-80% to 90-95% during the year.

2 more points management made on order book & pipeline

Sigachi Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹117 Cr, net loss ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Sigachi Indust.'s management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Sigachi Industries Ltd Q4 FY26 results?

Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reaching

What is Sigachi Industries Ltd share price analysis?

Sigachi Industries Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 30.6 with a market cap of ₹995 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sigachi Industries Ltd planning capital expenditure?

Ongoing CapEx for expanding MCC capacity by 12,000 metric tons at Dahej H2 with a cost of around INR 106 crores.

Keep Sigachi Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.